UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | March 7, 2023 |
Accession Number: | 0001213900-23-015473 | ||||||
Submission Type: | POS AM | ||||||
|
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | March 7, 2023 |
Accession Number: | 0001213900-23-015473 | ||||||
Submission Type: | POS AM | ||||||
|
Save time and jump to the most important pieces.
SC 13G/A - CYREN Ltd. (0001084577) (Subject)
SC 13G/A - CYREN Ltd. (0001084577) (Subject)
SC 13G - CYREN Ltd. (0001084577) (Subject)
15-12G - CYREN Ltd. (0001084577) (Filer)
EFFECT - CYREN Ltd. (0001084577) (Filer)
EFFECT - CYREN Ltd. (0001084577) (Filer)
4 - CYREN Ltd. (0001084577) (Issuer)
4/A - CYREN Ltd. (0001084577) (Issuer)
4 - CYREN Ltd. (0001084577) (Issuer)
Q3 Enterprise Anti-Phishing ARR Grows 74% Year-over-Year Driven by Increased DemandMCLEAN, VA / ACCESSWIRE / November 14, 2022 / Cyren (NASDAQ:CYRN) today announced its third quarter 2022 financial results for the period ending September 30, 2022.Cyren reported quarterly revenues of $5.8 million for the third quarter of 2022, a 4% increase compared to $5.6 million for the third quarter of 2021. Net loss from continuing operations was $5.5 million for 2022, compared to a net loss of $6.1 million in 2021."We are pleased to see year-over-year revenue growth in our third quarter, driven by both our enterprise anti-phishing business as well as our threat detection OEM business," said Brett Jackso
MCLEAN, VA / ACCESSWIRE / November 2, 2022 / - Cyren (NASDAQ:CYRN) today announced it will release its third quarter financial results on Monday, November 14, 2022, after U.S. markets close.The company will also host a conference call at 4:30 p.m. Eastern Time on Monday, November 14, 2022.US: 1-877-407-0312International: 1-201-389-0899The call will be simultaneously webcast live on the investor relations section of Cyren's website at http://ir.cyren.com, or by using the following link: https://www.webcast-eqs.com/register/cyren11142022_en/enFor those unable to participate in the live conference call, a replay will be available until November 30, 2022. To access the replay, the U.S. dial-in n
MCLEAN, VA / ACCESSWIRE / August 1, 2022 / Cyren (NASDAQ:CYRN) today announced it will release its second quarter financial results on Monday, August 15, 2022, after U.S. markets close.The company will also host a conference call at 4:30 p.m. Eastern Time on Monday, August 15, 2022.US: 1-877-407-0667International:1-201-389-0899The call will be simultaneously webcast live on the investor relations section of Cyren's website at http://ir.cyren.com, or by using the following link: https://www.webcast-eqs.com/register/cyren20220815_en/en.For those unable to participate in the live conference call, a replay will be available until August 30, 2022. To access the replay, the U.S. dial-in number is
MCLEAN, VA / ACCESSWIRE / February 22, 2023 / Cyren (NASDAQ:CYRN), a provider of email inbox security and threat detection solutions, today announced that, in response to its planned liquidation, the Company received written notice from Nasdaq, advising it that based upon Nasdaq's review and pursuant to Listing Rule 5101, 5110(b) and IM-5101-1, Nasdaq has determined to delist the Company's securities from The Nasdaq Stock Market. The Company does not plan to appeal Nasdaq's determination.Therefore, the Company expects, based on Nasdaq's written notice, that the trading of the Company's ordinary shares will be suspended at the opening of business on March 3, 2023, and that Nasdaq will file a
MCLEAN, VA / ACCESSWIRE / February 22, 2023 / Cyren (NASDAQ:CYRN), a provider of email inbox security and threat detection solutions, today announced that, in response to its inability to secure additional sources of liquidity or consummate a going concern sale, as previously disclosed, the Board of Directors of the Company approved a plan to cease operations and commence insolvency proceedings for the Company and to liquidate its wholly-owned subsidiaries under applicable insolvency and other laws.The Company intends to commence a voluntary bankruptcy proceeding in Israel by filing an insolvency application with the Tel Aviv District Court. The Company also approved (i) its US subsidiary, C
MCLEAN, VA / ACCESSWIRE / February 21, 2023 / Cyren (NASDAQ:CYRN), a provider of threat detection solutions, today announced it has entered into a non-binding, non-exclusive letter of intent (LOI) with Opin Kerfi (OK) to sell certain of its Iceland-based assets associated with Cyren's anti-malware business, including products, technology and related IP. The purchase price was not disclosed.Cyren previously announced a global reduction of substantially all of its workforce due to liquidity challenges. The sale of the anti-malware business assets to OK is an asset monetization opportunity for Cyren that would enable Cyren's anti-malware customers continued access to Cyren's anti-malware produc
Matt Mosley to lead execution of cyber startup's strategy and operations COLUMBIA, Md., Oct. 19, 2022 /PRNewswire-PRWeb/ -- Foretrace, a cyber security startup, today announced the appointment of industry veteran Matt Mosley as President and Chief Operating Officer. Reporting to the CEO, Mosley will lead the execution of Foretrace's go-to-market strategy and oversee its operations. "Matt is an exceptional business leader who brings a unique skill set to Foretrace. He has demonstrated the ability to grow and lead startups, build high-performing teams, and develop products from concept to market", said Nick Ascoli, Founder and CEO of Foretrace. "As COO, Matt will work closely with me and the r
MCLEAN, VA / ACCESSWIRE / January 27, 2021 / Cyren (NASDAQ:CYRN), a provider of email security and threat intelligence solutions, today announced that Kenneth Tarpey will join the Company as Chief Financial Officer, replacing Michael Myshrall, who, after ten years with the company, is moving on to pursue other interests. Mr. Tarpey joins Cyren with over 30 years of financial leadership experience in both public and private technology companies. Most recently, Mr. Tarpey was the Chief Financial Officer of Videology, a $200 million video advertising platform company. He previously served as the CFO of comScore (SCOR), a publicly traded digital analytics company with over 1,300 employees and
Gainers Exela Technologies, Inc. (NASDAQ:XELA) shares surged 45% to $0.0701 after the company announced $51 million of new funding, amendment increases existing securitization facility to $185 million and other related transactions. BioRestorative Therapies, Inc. (NASDAQ:BRTX) shares jumped 34.7% to $3.76 after the company announced the United States Patent and Trademark Office has issued a notice of allowance for a patent application related to the Company's metabolic ThermoStem program. Diversified Healthcare Trust (NASDAQ:DHC) surged 30% to $1.21 after the company posted a profit for the fourth quarter. Desktop Metal, Inc. (NYSE:DM) gained 23% to $1.8550 after the company reported
Gainers Lucira Health, Inc. (NASDAQ:LHDX) jumped 354% to $0.6369 after the company announced FDA authorization for its at-home combination COVID-19 & flu test. ContraFect Corporation (NASDAQ:CFRX) shares jumped 66% to $5.14. ObsEva SA (NASDAQ:OBSV) jumped 56.5% to $0.1299. ObsEva shares dropped over 50% on Friday after the company announced strategic reorganization to consolidate operations in Switzerland. Blackboxstocks Inc. (NASDAQ:BLBX) rose 33% to $0.7300. Blackboxstocks said it sees Q4 revenue of $950K-$1.05M. Moolec Science SA (NASDAQ:MLEC) gained 25.3% to $5.14. AERWINS Technologies Inc. (NASDAQ:AWIN) shares rose 24.5% to $2.0909 after gaining more than 10% on Friday. Fisker
Gainers Lucira Health, Inc. (NASDAQ:LHDX) rose 228.5% to $0.46 in pre-market trading after the FDA authorized Lucira's over-the-counter at-home test to detect both influenza and COVID-19 viruses. ObsEva SA (NASDAQ:OBSV) rose 60.3% to $0.1331 in pre-market trading. ObsEva shares dropped over 50% on Friday after the company announced strategic reorganization to consolidate operations in Switzerland. Monopar Therapeutics Inc. (NASDAQ:MNPR) rose 19.8% to $3.92 in pre-market trading. Troika Media Group, Inc. (NASDAQ:TRKA) rose 16.4% to $0.3550 in pre-market trading after gaining over 17% on Friday. Inpixon (NASDAQ:INPX) rose 13% to $1.30 in pre-market trading. Seagen Inc. (NASDAQ:SGEN) ro